VentriPoint Diagnostics Ltd. VPTDF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -1.40% | 361.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.40% | 361.29% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -1.40% | 361.29% | |||
| SG&A Expenses | -0.89% | -32.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.88% | -27.83% | |||
| Operating Income | 0.89% | 30.11% | |||
| Income Before Tax | 0.88% | -175.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.88% | -247.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.88% | -247.45% | |||
| EBIT | 0.89% | 30.11% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 3.70% | -200.00% | |||
| Normalized Basic EPS | 0.00% | 36.00% | |||
| EPS Diluted | 3.70% | -200.00% | |||
| Normalized Diluted EPS | 0.00% | 36.00% | |||
| Average Basic Shares Outstanding | 0.00% | 11.15% | |||
| Average Diluted Shares Outstanding | 0.00% | 11.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||